Coastlands Capital LP - 17 Jun 2026 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Jun 2026, 10:30:53 UTC
Prior SEC filing
29 May 2026
Next SEC filing
29 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP

Key filing fact

Coastlands Capital LP filed Form 4 for Pasithea Therapeutics Corp. (KTTA) on 22 Jun 2026.

Key facts

  • This page summarizes Coastlands Capital LP's Form 4 filing for Pasithea Therapeutics Corp. (KTTA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Jun 2026, 10:30.

Change

  • Previous filing in this sequence was filed on 29 May 2026.
  • Current net transaction value: +$53,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002068530 Primary reporting owner

Coastlands Capital LP

Relationship
10%+ Owner
Address
601 CALIFORNIA STREET, SUITE 1210, SAN FRANCISCO
Signature
/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP
Signature date
22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KTTA transaction

Common Stock

Purchase

Transaction value
$53,000
Shares
+100,000
Change %
+2.7%
Price
$0.5300
Shares after
3,835,035
Date
17 Jun 2026
Ownership
By Coastlands Capital LP
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .